Research
Metabolic adaptation
SGLT-2 inhibitors lower blood sugar independently of insulin, reduce heart failure risk, slow kidney disease progression, and possess senolytic properties.
SGLT-2 inhibitors may be beneficial for patients with diabetes and related complications.
StrongSupportsmedium confidence
SGLT-2 inhibitors lower blood sugar independently of insulin, reduce heart failure risk, slow kidney disease progression, and possess senolytic properties that may enhance longevity.
Why this rating
The review summarizes findings from multiple studies.
Source
A comprehensive review of the multisystem benefits of antidiabetic drugs in aging beyond glycemic control
Fatema Tuz Zohora et al. · Translational Medicine of Aging · 2025
DOI 10.1016/j.tma.2025.08.005
reviewCited 1×
Read the paper DOI resolved against Crossref · corpus check 2026-06-10
More from this paper
Related findings · Metabolic adaptation
This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →